Transformers & Rectifiers India Ltd Q1 FY2027 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/liy2aehi1bf12c663ubelg3g.pdf

Key Takeaways


The Changodar Drag: Expansion Eating Its Own Output

Satyen Mamtora: "So looking at the geopolitical situation, we have protected ourselves until December, and we are pretty much sure that all our backward integration plants will be ready by December."

Order Book & Demand Visibility


Backward Integration: The Margin Thesis, Delayed

FacilityCommissioning Timeline
CRGO processingAlready operational
CTC plantQ2 FY27
Pressboard and insulationQ3 FY27
RIP bushingsQ4 FY27
Fabrication facilityQ1 FY28
Satyen Mamtora: "In transformer industry, where component availability remains a key bottleneck globally, we believe backward integration will become a significant competitive advantage for TARIL over the coming years."

Margins: Consolidated Strength, Standalone Pressure


HVDC & Technology Bets

Satyen Mamtora: "We are looking at hybrid. These are basically not patented, but manufacturing secrecy kind of thing. So we would not like to discuss any further on this, but it will be based on hybrid systems."

Balance Sheet & Funding


Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growth25% in FY27; 30% across all sectors this yearFY27
EBITDA margin16% standaloneFY27
PAT margin9% to 10%FY27
Changodar expansion completionUtilization to improve progressively thereafter; 60-65% this year, 80-85% next yearAugust 2026
CTC facility commissioningBackward integration step oneQ2 FY27
Pressboard and insulation facilityBackward integration step twoQ3 FY27
RIP bushings facilityBackward integration step threeQ4 FY27
Fabrication facilityBackward integration step fourQ1 FY28
Backward integration margin benefit200-300 bps, gradual from FY28Starting FY28
HVDC manufacturing readinessPGCIL empanelment for first trial order to follow15-16 months
Revenue targetINR8,000 croresFY29
FY28 guidanceClear guideline to be providedQ4 FY27
Working capital days120 to 130 days on averageOngoing
Inventory reductionGradual reduction startingQ4 FY28
Moraiya utilization80-85% targetGoing forward

Key Metrics

MetricQ1 FY27
Standalone revenue₹559 cr, +10% YoY
Consolidated revenue₹572 cr
Standalone EBITDA₹87 cr, margin 15.6%
Consolidated EBITDA₹110 cr, margin 19.2%
Standalone PAT₹50 cr, margin 8.9%
Consolidated PAT₹64 cr
FY27 revenue growth guidance25%
FY27 standalone EBITDA margin guidance16% (includes other income)
FY27 consolidated EBITDA margin guidance20% to 21% or beyond
FY27 PAT margin guidance9% to 10%
Unexecuted order book₹6,630 cr, +26% YoY
Order inflow₹2,114 cr, +218% YoY
Inquiries under negotiation₹23,000 cr, win ratio historically 10% to 15%
Standalone debt-to-equity0.3x, debt ₹424 cr vs net worth ₹1,410 cr (FY26)
Standalone debt-to-EBITDA1.1x (FY26)
Net working capital days~170 days, inventory ~85 days, receivables 130 days (FY26)
Standalone ROCE19.1% in FY26, improved from 11.1% in FY21
Standalone ROE15.7% in FY26, improved from 2.1% in FY21
5-year standalone revenue CAGR27%
5-year standalone PAT CAGR101%
Changodar capacity utilization27% in Q1, impacted by ongoing expansion; expected 60%–65% in FY27, 80%–85% from FY28
Moraiya capacity utilization57% in Q1, expected to reach 80%–85%
Backward integration margin benefit200–300 bps expected from FY28 onward
Export revenue share10% to 15%, will not exceed 15%
Revenue target by FY29~₹8,000 cr (revised from earlier $1 bn target)